As of Apr 27
| +0.05 / +1.16%|
The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 1.40. The median estimate represents a +26.44% increase from the last price of 4.35.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since April, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.